TMPRSS2 / ERG Breakapart

Patoloji problari

Probe specification TMPRSS2, 21q22.2-q22.3, Red TMPRSS2, 21q22.2-q22.3, Green ERG, 21q22.13-q22.2, Blue The TMPRSS2/ERG Deletion/Breakapart probe is a three colour probe that consists of green probes and red probes positioned on each side of the TMPRSS2 gene, as well as three blue probes that cover the centromeric region of the ERG gene, up to D21S1439 marker. Probe information Recent studies suggest that over 50% of prostate tumours may carry a chromosomal rearrangement of chromosome 21q221. The genes involved are the androgen-inducible TMPRSS2 (Transmembrane protease, serine 2 (21q22.3)) and an ETS (E-twenty six) family transcription factor, ERG (v-ets erythroblastosis virus E26 oncogene like (21q22.2))1.

Product code : LPS 021

Explanation
Downloadable Files
Order form

Probe specification

TMPRSS2, 21q22.2-q22.3, Red

TMPRSS2, 21q22.2-q22.3, Green

ERG, 21q22.13-q22.2, Blue

The TMPRSS2/ERG Deletion/Breakapart probe is a three colour probe that consists of green probes and red probes positioned on each side of the TMPRSS2 gene, as well as three blue probes that cover the centromeric region of the ERG gene, up to D21S1439 marker.

Probe information

Recent studies suggest that over 50% of prostate tumours may carry a chromosomal rearrangement of chromosome 21q221. The genes involved are the androgen-inducible TMPRSS2 (Transmembrane protease, serine 2 (21q22.3)) and an ETS (E-twenty six) family transcription factor, ERG (v-ets erythroblastosis virus E26 oncogene like (21q22.2))¹.

An apparent intrachromosomal deletion of 3Mb on chromosome 21 fuses TMPRSS2 to ERG. The rearrangement places ERG under the androgen-regulated transcriptional control of TMPRSS2². This fusion is associated with disease progression and the rearrangement in prostate cancer may account for molecular and clinical heterogeneity³. This represents an important subclassification of prostate cancer from a biological and a clinical standpoint³.